Percheron Therapeutics LimitedASX: PER

Completion of avicursen (ATL1102) toxicology study

Sep 30, 2024 at 3:28 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment